线粒体单胺氧化酶B介导的氧化应激介导焦磷酸钙晶体诱导的关节炎
在两种小鼠焦磷酸钙晶体诱导关节炎模型中,预防性和治疗性给予临床级单胺氧化酶B抑制剂(雷沙吉兰和沙芬酰胺)可抑制促炎细胞因子和趋化因子释放,显著减轻踝关节肿胀(雷沙吉兰50.3% vs 17.1%,P<0.001;沙芬酰胺23.1%,P=0.005),并抑制巨噬细胞活性氧爆发和线粒体功能障碍,通过抑制NF-κB和STAT3通路减少NLRP3炎症小体激活。
要点
- 单胺氧化酶B抑制剂雷沙吉兰和沙芬酰胺在预防和治疗方案中均减轻小鼠晶体性关节炎炎症。
- 雷沙吉兰和沙芬酰胺分别使踝关节肿胀降低50.3%和23.1%(P<0.001和P=0.005)。
- 机制涉及抑制活性氧爆发、线粒体功能障碍及NF-κB/STAT3通路介导的NLRP3炎症小体激活。
核心结论
- 单胺氧化酶B抑制剂在晶体诱导关节病小鼠模型中减轻炎症,提示单胺氧化酶B是治疗此类疾病的有前景靶点。
研究设计与样本
- 在两种小鼠焦磷酸钙晶体诱导关节炎模型中测试假说,测量细胞因子和趋化因子水平及免疫细胞募集,每组n>6只小鼠。
- 单胺氧化酶B抑制剂(雷沙吉兰和沙芬酰胺)在晶体注射前或注射后给药。
- 体外用焦磷酸钙晶体刺激预处理的巨噬细胞,评估单胺氧化酶B抑制剂对促炎细胞因子和线粒体功能的影响。
主要发现
- 预防性和治疗性体内方案中,单胺氧化酶B抑制剂均抑制促炎细胞因子(白细胞介素[IL]-6和IL1-β)及趋化因子(CXCL10、CXCL1、CCL2和CCL5)释放(每组n>6只小鼠)。
- 单胺氧化酶B抑制剂显著减轻踝关节肿胀:雷沙吉兰组50.3% vs 17.1%(P<0.001),沙芬酰胺组23.1%(P=0.005)。
- 机制上,单胺氧化酶B抑制剂抑制焦磷酸钙晶体在分离巨噬细胞中触发的活性氧爆发和线粒体功能障碍。
- 单胺氧化酶B抑制剂通过抑制NF-κB和STAT3通路减少细胞因子分泌和NLRP3炎症小体激活。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Calcium pyrophosphate (CPP) crystal deposition in the joints is associated with a heterogeneous set of debilitating syndromes characterized by inflammation and pain, for which no effective therapies are currently available. Because we found that the mitochondrial enzyme monoamine oxidase B (MAO-B) plays a fundamental role in promoting inflammatory pathways, this study aims at assessing the efficacy of two clinical-grade inhibitors (iMAO-Bs) in preclinical models of this disease to pave the way for a novel treatment. METHODS: We tested our hypothesis in two murine models of CPP-induced arthritis, by measuring cytokine and chemokine levels, along with immune cell recruitment. iMAO-Bs (rasagiline and safinamide) were administered either before or after crystal injection. To elucidate the molecular mechanism, we challenged in vitro primed macrophages with CPP crystals and assessed the impact of iMAO-Bs in dampening proinflammatory cytokines and in preserving mitochondrial function. RESULTS: Both in preventive and therapeutic in vivo protocols, iMAO-Bs blunted the release of proinflammatory cytokines (interleukin [IL]-6 and IL1-β) and chemokines (CXCL10, CXCL1, CCL2 and CCL5) (n > 6 mice/group). Importantly, they also significantly reduced ankle swelling (50.3% vs 17.1%; P < 0.001 and 23.1%; P = 0.005 for rasagiline and safinamide, respectively). Mechanistically, iMAO-Bs dampened the burst of reactive oxygen species and the mitochondrial dysfunction triggered by CPP crystals in isolated macrophages. Moreover, iMAO-Bs blunted cytokine secretion and NLRP3 inflammasome activation through inhibition of the NF-κB and STAT3 pathways. CONCLUSION: iMAO-Bs dampen inflammation in murine models of crystal-induced arthropathy, thereby uncovering MAO-B as a promising target to treat these diseases.
引用
- Venegas FC, Sánchez-Rodríguez R, Luisetto R, et al. Oxidative Stress by the Mitochondrial Monoamine Oxidase B Mediates Calcium Pyrophosphate Crystal-Induced Arthritis. Arthritis Rheumatol. 2023. PMID: 37695218. doi:10.1002/art.42697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。